Literature DB >> 30426203

The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.

Susanne Walter1, Thorsten Jumpertz1, Melanie Hüttenrauch2, Isabella Ogorek1, Hermeto Gerber3,4, Steffen E Storck5, Silvia Zampar2, Mitko Dimitrov6, Sandra Lehmann1, Klaudia Lepka7, Carsten Berndt7, Jens Wiltfang2, Christoph Becker-Pauly8, Dirk Beher9, Claus U Pietrzik5, Patrick C Fraering3, Oliver Wirths10, Sascha Weggen11.   

Abstract

Brain accumulation and aggregation of amyloid-β (Aβ) peptides is a critical step in the pathogenesis of Alzheimer's disease (AD). Full-length Aβ peptides (mainly Aβ1-40 and Aβ1-42) are produced through sequential proteolytic cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. However, studies of autopsy brain samples from AD patients have demonstrated that a large fraction of insoluble Aβ peptides are truncated at the N-terminus, with Aβ4-x peptides being particularly abundant. Aβ4-x peptides are highly aggregation prone, but their origin and any proteases involved in their generation are unknown. We have identified a recognition site for the secreted metalloprotease ADAMTS4 (a disintegrin and metalloproteinase with thrombospondin motifs 4) in the Aβ peptide sequence, which facilitates Aβ4-x peptide generation. Inducible overexpression of ADAMTS4 in HEK293 cells resulted in the secretion of Aβ4-40 but unchanged levels of Aβ1-x peptides. In the 5xFAD mouse model of amyloidosis, Aβ4-x peptides were present not only in amyloid plaque cores and vessel walls, but also in white matter structures co-localized with axonal APP. In the ADAMTS4-/- knockout background, Aβ4-40 levels were reduced confirming a pivotal role of ADAMTS4 in vivo. Surprisingly, in the adult murine brain, ADAMTS4 was exclusively expressed in oligodendrocytes. Cultured oligodendrocytes secreted a variety of Aβ species, but Aβ4-40 peptides were absent in cultures derived from ADAMTS4-/- mice indicating that the enzyme was essential for Aβ4-x production in this cell type. These findings establish an enzymatic mechanism for the generation of Aβ4-x peptides. They further identify oligodendrocytes as a source of these highly amyloidogenic Aβ peptides.

Entities:  

Keywords:  ADAMTS proteases; Alzheimer’s disease; Amyloidosis; Aβ peptides; N-truncation; Neurodegeneration; Oligodendrocytes

Mesh:

Substances:

Year:  2018        PMID: 30426203     DOI: 10.1007/s00401-018-1929-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  17 in total

Review 1.  Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing.

Authors:  José J M Vitória; Diogo Trigo; Odete A B da Cruz E Silva
Journal:  Cell Mol Life Sci       Date:  2022-01-28       Impact factor: 9.261

2.  Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders.

Authors:  Julien Bryois; Daniela Calini; Will Macnair; Lynette Foo; Eduard Urich; Ward Ortmann; Victor Alejandro Iglesias; Suresh Selvaraj; Erik Nutma; Manuel Marzin; Sandra Amor; Anna Williams; Gonçalo Castelo-Branco; Vilas Menon; Philip De Jager; Dheeraj Malhotra
Journal:  Nat Neurosci       Date:  2022-08-01       Impact factor: 28.771

3.  The Blood-Brain Barrier in Alzheimer's Disease.

Authors:  Steffen E Storck; Anika M S Hartz; Claus U Pietrzik
Journal:  Handb Exp Pharmacol       Date:  2022

4.  Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer's disease.

Authors:  Jing-Fei Chen; Kun Liu; Bo Hu; Rong-Rong Li; Wendy Xin; Hao Chen; Fei Wang; Lin Chen; Rui-Xue Li; Shu-Yu Ren; Lan Xiao; Jonah R Chan; Feng Mei
Journal:  Neuron       Date:  2021-06-07       Impact factor: 18.688

5.  Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models.

Authors:  Sathish Kumar; Cynthia A Lemere; Jochen Walter
Journal:  Acta Neuropathol Commun       Date:  2020-07-29       Impact factor: 7.801

Review 6.  The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis?

Authors:  Pierre Dourlen; Devrim Kilinc; Nicolas Malmanche; Julien Chapuis; Jean-Charles Lambert
Journal:  Acta Neuropathol       Date:  2019-04-13       Impact factor: 17.088

Review 7.  Impacts of exercise interventions on different diseases and organ functions in mice.

Authors:  Shanshan Guo; Yiru Huang; Yan Zhang; He Huang; Shangyu Hong; Tiemin Liu
Journal:  J Sport Health Sci       Date:  2019-07-13       Impact factor: 7.179

8.  N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer's disease.

Authors:  S Zampar; H W Klafki; K Sritharen; T A Bayer; J Wiltfang; A Rostagno; J Ghiso; L A Miles; O Wirths
Journal:  Neuropathol Appl Neurobiol       Date:  2020-06-29       Impact factor: 8.090

Review 9.  The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics.

Authors:  Sarah A Kent; Tara L Spires-Jones; Claire S Durrant
Journal:  Acta Neuropathol       Date:  2020-07-29       Impact factor: 15.887

Review 10.  New Insights into ADAMTS Metalloproteases in the Central Nervous System.

Authors:  Yamina Mohamedi; Tania Fontanil; Teresa Cobo; Santiago Cal; Alvaro J Obaya
Journal:  Biomolecules       Date:  2020-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.